Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acumen Pharmaceuticals Inc (NQ: ABOS ) 5.650 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 5.650 Bid (Size) 4.410 (1) Ask (Size) 7.480 (1) Prev. Close 5.650 Today's Range 5.650 - 5.650 52wk Range 3.020 - 19.46 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year Top News More News Recap: Acumen Pharmaceuticals Q2 Earnings August 15, 2022 Acumen Pharmaceuticals (NASDAQ:ABOS) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Conferences July 26, 2022 From Acumen Pharmaceuticals, Inc. Via Globe NewsWire Performance YTD -16.05% -16.05% 1 Month -3.75% -3.75% 3 Month +54.79% +54.79% 6 Month +2.73% +2.73% 1 Year -63.05% -63.05% More News Read More Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday July 26, 2022 Via Benzinga The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal July 28, 2021 Via Benzinga Exposures COVID-19 Earnings Scheduled For August 15, 2022 August 15, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 July 15, 2022 Via Benzinga A Tale of Tangles Chapter Three: The Desert Expanse April 28, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday March 30, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022 June 30, 2022 Via Benzinga Earnings Scheduled For March 28, 2022 March 28, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Friday April 01, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Thursday March 31, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 29, 2022 Via Benzinga More Specificity is What the Doctor Ordered December 14, 2021 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday January 25, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 07, 2021 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022 January 21, 2022 Via Benzinga 45 Stocks Moving In Tuesday's Mid-Day Session September 07, 2021 Via Benzinga 52 Weeks High And Low Article January 11, 2022 Via Benzinga The Past Week's Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More July 11, 2021 Via Benzinga 72 Biggest Movers From Yesterday September 08, 2021 Via Benzinga The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision And Conference Presentations In A Light Week July 03, 2021 Via Talk Markets Exposures COVID-19 Product Safety The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs July 29, 2021 Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021 July 26, 2021 Via Benzinga The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week July 03, 2021 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
